Asia Pacific Vapor Deposition Equipment Market Outlook On The Basis Of Technology, Application, Region And Forecast To 2028 : Grand View Research Inc.

San Francisco, 4 Apr 2022: The Report Asia Pacific Vapor Deposition Equipment Market Size, Share & Trends Analysis Report By Technology (CVD, PVD), By Application (Data Storage, Medical Equipment, Data Storage, Microelectronics), And Segment Forecasts, 2021 – 2028

The Asia Pacific vapor deposition equipment market size is anticipated to reach USD 19.15 billion by 2028, registering a CAGR of 6.4% over the forecast period, according to a new report by Grand View Research, Inc. Increasing semiconductor manufacturing coupled with rising demand for solar PV products in Asia Pacific is anticipated to drive the market growth. The rapid growth in the medical device industry, attributed to the increased investments in medical infrastructure during the pandemic, is expected to have a positive impact on the market. The medical device manufacturers are in need of wear-resistant and biocompatible coatings, which are provided by vapor deposition technology.

Ongoing developments and innovations in connectivity, communications, advanced software, the automotive industry, and data centers are projected to create a substantial demand for microelectronics in the region over the forecast period. This, in turn, is expected to have a positive impact on the vapor deposition equipment market. Key strategies adopted by various manufacturers include collaboration with coating companies and providing them with the necessary technology and equipment for coating. For instance, in October 2020, Vergason Technology, Inc., partnered with Helios Coatings Inc. to utilize Physical Vapor Deposition (PVD) wheel coating technology.

Access Research Report of Asia Pacific Vapor Deposition Equipment Market @ https://www.grandviewresearch.com/industry-analysis/asia-pacific-vapor-deposition-equipment-market-report

Asia Pacific Vapor Deposition Equipment Market Report Highlights

• Microelectronics accounted for the largest revenue share in 2020 owing to increased demand for durable coatings as vapor deposition allows the coated material to possess unique properties aiding them to integrate with microelectronics
• The Chemical Vapor Deposition (CVD) segment led the global market in 2020 and is expected to register the fastest CAGR from 2021 to 2028
• The medical equipment application segment is projected to witness the fastest CAGR of 7.6% over the forecast period
• This growth is credited to its ability to provide a wear-resistant & hard coating on medical devices and surgical instruments
• China accounted for the maximum revenue share in 2020 due to the heavy investments, a robust economic recovery, high disposable income levels, and improved private demand
• End users are focusing on new product launches with vapor deposition techniques to expand their product portfolios
• For instance, In March 2020, Roca Sanitario SA introduced Everlux finishes, a PVD technique to offer impact- and scratch-resistant products

List of Key Players of Asia Pacific Vapor Deposition Equipment Market

• Buhler Alzenau GmbH
• Vacuum Techniques Pvt. Ltd.
• Ningbo Danko Vacuum Technology Co., Ltd.
• Vergason Technology, Inc.
• Vapor Technologies, Inc.
• AJA International, Inc.
• Kobe Steel, Ltd.
• Milman Thin Film Systems Pvt. Ltd.
• Foshan Foxin Vacuum Technology Co., Ltd.
• IKS PVD Technology (Shenyang) Co., Ltd.

Access Press Release of Asia Pacific Vapor Deposition Equipment Market @ https://www.grandviewresearch.com/press-release/asia-pacific-vapor-deposition-equipment-market-analysis

Swine Vaccines Market Segmented On The Basis Of Type, Product, Region And Forecast 2028: Grand View Research Inc.

San Francisco, 4 Apr 2022: The Report Swine Vaccines Market Size, Share & Trends Analysis Report By Product (Recombinant, Inactivated), By Type (Pseudorabies, Porcine Circovirus Type 2), By Region (Asia Pacific, North America), And Segment Forecasts, 2021 – 2028

The global swine vaccines market size is expected to reach USD 2.09 billion by 2028, registering a CAGR of 4.9% over the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of diseases, a surge in the demand for animal protein, and growth in R&D expenditure for vaccines innovation are driving the market growth. Porcine Parvovirus (PPV), Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine circovirus type 2 (PCV2), Foot & Mouth Disease, Classical Swine Fever, and others remain to be extremely prevalent diseases in pig farms affecting economic losses.

The COVID-19 pandemic directly or indirectly impacted the business, results of operations, and financial conditions of market players. The Animal Health business was confronted with various production and supply bottlenecks because of the COVID-19 pandemic; this consists of delays in the delivery of raw materials and active ingredients and capacity constraints in freight transport (especially air and sea freight). While on the other side, the industry has expanded its research at an unprecedented pace in animal health. Thereby, the COVID-19 pandemic significantly impacted the market growth.

In addition, the growing investments by key players to develop advanced products for better diagnosis are likely to propel market growth. For instance, in May 2020, Indian Immunologicals Ltd. introduced the Classical Swine Fever vaccine. Stating that it has introduced the product under the brand name ‘Raksha Class’. This is a unique cell culture technology-based vaccine developed in cooperation with the Indian Veterinary Research Institute, Bareilly.

Key players are involved in strategic initiatives, such as joint ventures, mergers, acquisitions, and new product launches to gain a higher market share. For instance, in February 2020, the new vaccine created by ICAR, Indian Veterinary Research Institute (IVRI), based in Uttar Pradesh, was much cheaper than an already existing one. It costs only Rs 2 for each dose over the present vaccine’s rate of Rs 15-20 for each dose and an imported Korean vaccine rate of Rs 30 for each dose.

Access Research Report of Swine Vaccines Market @ https://www.grandviewresearch.com/industry-analysis/swine-vaccines-market-report

Swine Vaccines Market Report Highlights

• The inactivated vaccines segment dominated the market in 2020 owing to its easy availability and low cost over others
• A recombinant vaccine is expected to register the fastest CAGR over the forecast period owing to the benefits, such as enhanced effectiveness, technology advancement, and increased long-standing prevention
• The Porcine circovirus type 2 segment dominated the market in 2020 due to the increased prevalence of the disease. Moreover, this is the quickly mutating of all single-stranded DNA (ssDNA) viruses, therefore it has a great mutation and recombination rate
• Asia Pacific is expected to register the fastest CAGR over the forecast period due to the growing cases of infectious diseases in swine, increasing awareness about animal health, rising demand for animal protein, and rapid urbanization

List of Key Players of Swine Vaccines Market

• Merck Animal Health
• Ceva
• Zoetis
• Boehringer Ingelheim GmbH
• Elanco
• Indian Immunologicals Ltd.
• BiogénesisBagó
• Phibro Animal Health
• KM Biologics
• HIPRA

Access Press Release of Swine Vaccines Market @ https://www.grandviewresearch.com/press-release/global-swine-vaccines-market

Surgical Sphincteroplasty Market Segment Analysis By Type, Region And Forecast Till 2028: Grand View Research Inc.

San Francisco, 4 Apr 2022: The Report Surgical Sphincteroplasty Market Size, Share & Trends Analysis Report By Type (Surgical, Non-Surgical), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2021 – 2028

The global surgical sphincteroplasty market size is expected to reach USD 2.67 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.6% from 2021 to 2028. Sphincteroplasty is a low-cost surgery as compared to other treatments anal incontinence. Factors such as low maintenance surgical tools and a 98.0% success ratio of sphincteroplasty have improved its adoption among surgeons.

The growing prevalence of anal incontinency (AI), increasing frequency of obstetric injury after childbirth, rise in innovative techniques to treat AI, and growing clinical studies are the key contributing factors propelling the growth of the market. Presence of fewer market players makes this a less competitive market. However, to strengthen their market position they are constantly involved in adopting developmental strategies like collaboration and acquisition with other market players.

Market leaders are also developing newer noninvasive surgical techniques for treating AI more effectively. Such initiatives are said to boost their market presence, fueling market growth. As a result of the COVID-19 pandemic, the healthcare system dealt with a lot of difficulties, such as the reduced impact of virus outbreaks, cancellation of elective and interventional surgeries, and most chronic pain therapies that were considered non-urgent. The market, however, is projected to be back on track and grow more effectively, by mid-2022.

Access Research Report of Surgical Sphincteroplasty Market @ https://www.grandviewresearch.com/industry-analysis/surgical-sphincteroplasty-market-report

Surgical Sphincteroplasty Market Report Highlights

• The surgery (sphincteroplasty) segment accounted for a revenue share of 28.1% in 2020, in the market
• The non-surgical sub-segment is expected to witness a CAGR of 6.9% during the forecast period. Factors like improved adoption of non- invasive surgeries by surgeons and caregivers and promising and satisfying outcomes have influenced market growth
• The non-surgical segment is further sub-divided into sacral nerve stimulation, vaginal balloon inserts, and others
• North America dominated the market and accounted for the largest revenue share of 34.9% in 2020
• Asia Pacific is anticipated to witness the fastest CAGR of 7.1% over the forecast period owing to the increasing geriatric population

List of Key Players of Surgical Sphincteroplasty Market

• Medtronic
• Hill-Rom Services, Inc.
• McKesson
• Braun
• Becton, Dickinson and Company
• Novo Surgical, Inc.
• Surgical Holdings
• Pelvalon
• Salix Pharmaceutical Inc.
• Johnson & Johnson

 Access Press Release of Surgical Sphincteroplasty Market @ https://www.grandviewresearch.com/press-release/global-surgical-sphincteroplasty-market

Precision Guided Munition Market Segmented On The Basis Of Product, Technology, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 1 Apr 2022: The Report Precision Guided Munition Market Size, Share & Trends Analysis Report By Product (Tactical Missiles, Loitering Munition), By Technology (GPS, INS), By Region (APAC, Europe), And Segment Forecasts, 2022 – 2030

The global precision guided munition market size is expected to reach USD 55.17 billion in 2030, registering a CAGR of 5.6% over the forecast period, according to a new report by Grand View Research Inc. The growing need for extremely accurate munitions for target attacking is anticipated to increase the demand for precision-guided munitions. Moreover, enhancements in precision attacking are likely to support the market. Growing political and territorial conflicts between major economies are likely to encourage the enhancements of their respective military and army operations. Precision attacking techniques are used in the army, air force, and naval forces, thus are likely to influence the market for precision-guided munitions over the forecast period.

Technological advancement in attacking components including missiles, rockets, mortars, artillery shells, bombs, and bullets to incorporate advanced positioning technologies are expected to enhance the market. Global Positioning System (GPS) and Semi-Active Lasers systems are popular positioning techniques to keep track of the targeted location for the attack. Prominent players including Lockheed Martin, Atlas Elektronik, Raytheon, Thales Group, BAE Systems, Northrop Grumman, and others are investing heavily in R&D activities to develop advanced technology war equipment. Moreover, ammunition manufacturers are focusing on the installation of a guiding mechanism in the components.

Access Research Report of Precision Guided Munition Market @ https://www.grandviewresearch.com/industry-analysis/precision-guided-munition-market

Precision Guided Munition Market Report Highlights

• The market for tactical missiles is projected to grow significantly over the forecast period on account of their increasing usage in all types of attacking mechanisms. Surface-to-surface and air-to-air tactical missiles are gaining popularity in the warfare equipment
• In the U.S., the revenue for precision guided munitions stood at USD 5.3 billion in 2021 and is expected to grow over the forecast period owing to increasing expenditures for military upgrade and enhancement in the attacking equipment
• In 2019, semi-active laser positioning technology accounted for the largest share owing to its prominence in the target positioning. Modern missiles and rockets are installed with these positioning mechanisms for guidance to the exact location
• The GPS technology is expected to register the fastest growth rate over the forecast period due to its prominent location tracking for the war equipment
• Conflicts between the U.S. and Iran are anticipated to enhance the military capabilities of the respective economies. Thereby, is expected to support the market for precision guided munition in the estimated time

List of Key Players of Precision Guided Munition Market

• Lockheed Martin
• Atlas Elektronik
• Raytheon
• Thales Group
• BAE Systems
• Northrop Grumman
• General Dynamics
• Elbit Systems

Access Press Release of Precision Guided Munition Market @ https://www.grandviewresearch.com/press-release/global-precision-guided-munition-market